Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01754363 · ClinicalTrials.gov registry record · NA
Survivorship of Attune Primary Total Knee Prosthesis
A NA study of Non-inflammatory Degenerative Joint Disease, sponsored by DePuy International.
- Active
- Registry status
- NA
- Development phase
- 1,542
- Enrollment target
- 20
- Study locations
NCT01754363: Active NA study of Non-inflammatory Degenerative Joint Disease, sponsored by DePuy International.
NCT01754363 is a NA study of Non-inflammatory Degenerative Joint Disease that is active but no longer recruiting, run by DePuy International. The registered enrollment target is 1,542 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% higher). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01754363, a NA study of Non-inflammatory Degenerative Joint Disease, is active but no longer recruiting, sponsored by DePuy International.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,542 participants
- Enrollment target
- 20
- Study locations
Study Summary
This post-marketing investigation will evaluate the long term (up to 15 years) survivorship of the Attune Primary Knee Prosthesis in patients with non-inflammatory degenerative joint disease. Data from Subjects who receive one of four knee configurations will be pooled to establish a contemporary dataset.
Primary Outcome
Kaplan-Meier survival analysis will be used to calculate the survivorship of all 4 configurations (CR FB, CR RP, PS FB, PS RP).
Conditions Studied
Interventions
- DEVICE Attune Primary Total Knee Replacement
Study Locations (20)
Other
- Monica Camputs O.L.V. Middelares - Antwerp
- UniversitatsKlinikum Heidelberg - Heidelberg
- Queen Mary Hospital - Hong Kong
- University Malaya Medical Centre - Kuala Lumpur
- Ascot Hospital - Auckland
Ohio
- Orthopedic One - Columbus
- OrthoNeuro - New Albany
Arizona
- Mayo Clinic Arizona - Scottsdale
California
- Orthopaedic Specialty Institute - Orange
Florida
- Florida Research Associates, LLC - DeLand
Indiana
- Center for Hip and Knee Surgery - Mooresville
Iowa
- University of Iowa Hospitals & Clinics - Iowa City
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,542 participants |
| Start Date | 2013-02-01 |
| Est. Completion | 2030-02-01 |
| Phase | NA |
What the registry record for NCT01754363 still lists
NCT01754363 is an interventional study that assigns participants to a tested intervention. Its 1,542 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% higher).
The record links to 1 condition, with Non-inflammatory Degenerative Joint Disease appearing as the primary indexed condition, and to 1 intervention - of which Attune Primary Total Knee Replacement is the first listed.
NCT01754363 names 20 study sites across 15 states, led by Other, Ohio, Arizona.
Frequently Asked Questions
What is clinical trial NCT01754363 about?
NCT01754363 is a clinical study titled "Survivorship of Attune Primary Total Knee Prosthesis". This post-marketing investigation will evaluate the long term (up to 15 years) survivorship of the Attune Primary Knee Prosthesis in patients with non-inflammatory degenerative joint disease. Data from Subjects who receive one of four knee configurations will be pooled to establish a contemporary da...
What is the current status of trial NCT01754363?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,542 participants. The study started on 2013-02-01. Estimated completion is 2030-02-01.
What conditions does trial NCT01754363 study?
This clinical trial studies the following conditions: Non-inflammatory Degenerative Joint Disease.
What interventions are being tested in trial NCT01754363?
The interventions under investigation include: Attune Primary Total Knee Replacement (DEVICE).
Who is sponsoring clinical trial NCT01754363?
This trial is sponsored by DePuy International, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01754363 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-inflammatory Degenerative Joint Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01754363's enrollment target sits among peer trials
1,542 65th of 2000 higher than 1,936 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- NCT06729775 · 1,546 participants · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
- NCT06842875 · 1,536 participants · NA
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI